GOODLIFE PHARMA
The computed 12-month bankruptcy probability of GOODLIFE PHARMA is 0.6% (low). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 14 yrs |
| Board | 3 |
| Locations | 1 |
| Publications | 6 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 29-07-2025 | 2025-00335064 |
| 31-12-2023 | volledig | 19-08-2024 | 2024-00360412 |
| 31-12-2022 | volledig | 28-07-2023 | 2023-00311150 |
| 31-12-2021 | volledig | 23-07-2022 | 2022-20224963 |
| 31-12-2020 | volledig | 29-07-2021 | 2021-45000068 |
| 31-12-2019 | volledig | 29-07-2020 | 2020-38900228 |
| 31-12-2018 | volledig | 19-07-2019 | 2019-34900002 |
| 31-12-2017 | volledig | 25-07-2018 | 2018-37900301 |
| 31-12-2016 | volledig | 28-07-2017 | 2017-38200531 |
| 31-12-2015 | volledig | 18-07-2016 | 2016-33300047 |
-
Sterq Management B.V.Legal entityDirector· perm. rep.: Koen PerenboomState Gazette act 25005441 (10-01-2025)Current21-11-2024 → present
-
LMW ManagementLegal entityDirector· perm. rep.: Megens, LucyState Gazette act 24018300 (29-01-2024)Current29-01-2024 → present
2 events
- 29-01-2024 Appointed· Director
- 29-01-2024 Appointed· Managing director
-
Current12-12-2023 → present
Historic, not recently confirmed (1)
-
Schewebach SCSLegal entityDirector· perm. rep.: Nathalie SchewebachState Gazette act 17178637 (20-12-2017)Not recently confirmedlast confirmed in an act from 2017
2 events
- 20-12-2017 Mandate renewed· Director
- 20-12-2017 Mandate renewed· Managing director
Former directors (1)
-
LMW Management SRLLegal entityDirector· perm. rep.: Lucy MegensState Gazette act 25005441 (10-01-2025)Former- → 21-11-2024
2 events
- 21-11-2024 Resigned· Director
- 21-11-2024 Resigned· Managing director
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Public limited company(014) |
| Incorporation | 11-04-2012 |
| Status | Active |
| Postal code | 1450 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 8 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
09-06-2026 Officer resignation · Officer appointment · Officer reappointment · Commercial fund declaration
- Filing: 2026-06-01 · GOODLIFE PHARMA
- Officer resignation: date: 2026-03-02, role: administrateur · Nathalie Schewebach
- Officer appointment: date: 2026-03-02, role: administrateur, term_end: 2032 · Belvita Healthcare SRL
- Officer appointment: date: 2026-03-02, role: administrateur, term_end: 2032 · Schewebach SRL
- Officer reappointment: date: 2026-03-02, role: administrateur, term_end: 2032 · Sterq Management BV
- Officer reappointment: date: 2026-03-02, role: administrateur délégué, term_end: 2032 · Sterq Management SRL
- Commercial fund declaration: date: 2026-03-02, type: single_shareholder · GOODLIFE PHARMA
- Power of attorney: date: 2026-03-02, purpose: publier les prises de décision écrites dans les annexes du Moniteur Belge et, dans ce contexte, de remplir toutes les formalités administratives · GOODLIFE PHARMA
- Power of attorney: date: 2026-03-02, purpose: faire tout ce qui est nécessaire ou utile en vue de l'inscription/modification de la société auprès de la Banque-Carrefour des Entreprises, des bureaux d'entreprises, des administrations fiscales (y compris la TVA et le cadastre), de la Commission d'enregistrement et des institutions de droit social et en vue de toutes les modifications ultérieures et de toutes les radiations éventuelles de ces inscriptions. · GOODLIFE PHARMA
- Publication: 2026-06-09
- Act object: Démission - nomination - communication en vertu de l'art. 2:8 §4
Technical details
{
"facts": [
{
"type": "filing",
"quote": "TRIBUNAL DE L\u0027ENTREPRISE 01 JUIN 2026",
"value": "2026-06-01",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale prend connaissance du d\u00E9mission de son mandat d\u0027administrateur de Nathalie Schewebach en effet au 2 mars 2026.",
"value": {
"date": "2026-03-02",
"role": "administrateur"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_appointment",
"quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale du 2 mars 2026 d\u00E9cide de nommer comme nouvels administrateurs jusqu\u0027\u00E0 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale de 2032: -Belvita Healthcare SRL...",
"value": {
"date": "2026-03-02",
"role": "administrateur",
"term_end": "2032"
},
"object": "e1",
"subject": "e3"
},
{
"type": "officer_appointment",
"quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale du 2 mars 2026 d\u00E9cide de nommer comme nouvels administrateurs jusqu\u0027\u00E0 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale de 2032: ... -Schewebach SRL...",
"value": {
"date": "2026-03-02",
"role": "administrateur",
"term_end": "2032"
},
"object": "e1",
"subject": "e5"
},
{
"type": "officer_reappointment",
"quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale d\u00E9cide de renommer le mandat d\u0027administrateur de la soci\u00E9t\u00E9 de droit des Pays-Bas Sterq Management BV... jusqu\u0027\u00E0 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale de 2032.",
"value": {
"date": "2026-03-02",
"role": "administrateur",
"term_end": "2032"
},
"object": "e1",
"subject": "e6"
},
{
"type": "officer_reappointment",
"quote": "Le conseil d\u0027administration d\u00E9cide \u00E0 l\u0027unanimit\u00E9 des voix de renommer comme administrateur d\u00E9l\u00E9gu\u00E9 pour un mandat de six ans prenant fin imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e annuelle de 2032, Sterq Management SRL...",
"value": {
"date": "2026-03-02",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"term_end": "2032"
},
"object": "e1",
"subject": "e7"
},
{
"type": "commercial_fund_declaration",
"quote": "Les administrateurs d\u00E9cident de d\u00E9poser le fait que toutes les actions sont r\u00E9unies en une seule main, ainsi que l\u0027identit\u00E9 de l\u0027actionnaire unique, aupr\u00E8s du Tribunal de l\u0027Entreprise...",
"value": {
"date": "2026-03-02",
"type": "single_shareholder"
},
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "Une procuration sp\u00E9ciale est donn\u00E9e \u00E0 M. Frank Dick... pour publier les prises de d\u00E9cision \u00E9crites dans les annexes du Moniteur Belge et, dans ce contexte, de remplir toutes les formalit\u00E9s administratives",
"value": {
"date": "2026-03-02",
"purpose": "publier les prises de d\u00E9cision \u00E9crites dans les annexes du Moniteur Belge et, dans ce contexte, de remplir toutes les formalit\u00E9s administratives"
},
"object": "e8",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale et le conseil d\u0027administration d\u00E9cident \u00E9galement \u00E0 l\u0027unanimit\u00E9 de donner procuration \u00E0 Kantoor Pieters-Dick \u0026 C\u00B0 SRL... pour faire tout ce qui est n\u00E9cessaire ou utile en vue de l\u0027inscription/modification de la soci\u00E9t\u00E9...",
"value": {
"date": "2026-03-02",
"purpose": "faire tout ce qui est n\u00E9cessaire ou utile en vue de l\u0027inscription/modification de la soci\u00E9t\u00E9 aupr\u00E8s de la Banque-Carrefour des Entreprises, des bureaux d\u0027entreprises, des administrations fiscales (y compris la TVA et le cadastre), de la Commission d\u0027enregistrement et des institutions de droit social et en vue de toutes les modifications ult\u00E9rieures et de toutes les radiations \u00E9ventuelles de ces inscriptions."
},
"object": "e9",
"subject": "e1"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 09/06/2026",
"value": "2026-06-09",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: D\u00E9mission - nomination - communication en vertu de l\u0027art. 2:8 \u00A74",
"value": "D\u00E9mission - nomination - communication en vertu de l\u0027art. 2:8 \u00A74",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 3342,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0845.590.372",
"kind": "company",
"name": "GOODLIFE PHARMA",
"attrs": {
"address": "Rue Fran\u00E7ois-Massart 27, 1450 Chastre",
"legal_form": "Soci\u00E9t\u00E9 Anonyme"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Nathalie Schewebach",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "company",
"name": "Belvita Healthcare SRL",
"attrs": {
"kvv": "85094684",
"address": "Naardepoort 2B, 1411 MA Naarden (Pays-Bas)"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Koen Perenboom",
"attrs": {}
},
{
"id": "e5",
"kbo": "0500.968.178",
"kind": "company",
"name": "Schewebach SRL",
"attrs": {
"address": "rue Fran\u00E7ois-Massart 27, 1450 Chastre"
}
},
{
"id": "e6",
"kbo": null,
"kind": "company",
"name": "Sterq Management BV",
"attrs": {
"kvv": "75520583",
"address": "Van Den Eyndestraat 3, 2582 EA \u0027S-Gravenhage (Pays-Bas)"
}
},
{
"id": "e7",
"kbo": null,
"kind": "company",
"name": "Sterq Management SRL",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Frank Dick",
"attrs": {
"rrn": null,
"role": "comptable fiscal ITAA",
"id_other": "10.452.253"
}
},
{
"id": "e9",
"kbo": "0459.893.529",
"kind": "company",
"name": "Kantoor Pieters-Dick \u0026 C\u00B0 SRL",
"attrs": {
"address": "Triestlaan 37, 9820 Merelbeke-Melle"
}
}
]
}10-01-2025 1 director appointed, 2 resigning
- Koen Perenboom, Bestuurder
- Lucy Megens, Bestuurder
- Lucy Megens, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lucy Megens",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "LMW Management SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-11-21",
"evidence_quote": "L\u0027actionnaire unique a pris connaissance du contenu de la lettre de d\u00E9mission de LMW Management SRL, repr\u00E9sent\u00E9e de fa\u00E7on permanente par Lucy Megens, par laquelle celle-ci d\u00E9missionne de son mandat d\u0027administrateur et d\u0027administrateur d\u00E9l\u00E9gu\u00E9 de la soci\u00E9t\u00E9 avec effet au 21 novembre 2024."
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Lucy Megens",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "LMW Management SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-11-21",
"evidence_quote": "L\u0027actionnaire unique a pris connaissance du contenu de la lettre de d\u00E9mission de LMW Management SRL, repr\u00E9sent\u00E9e de fa\u00E7on permanente par Lucy Megens, par laquelle celle-ci d\u00E9missionne de son mandat d\u0027administrateur et d\u0027administrateur d\u00E9l\u00E9gu\u00E9 de la soci\u00E9t\u00E9 avec effet au 21 novembre 2024."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Koen Perenboom",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Sterq Management B.V.",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-11-21",
"evidence_quote": "L\u0027actionnaire unique a d\u00E9cid\u00E9 de nommer la soci\u00E9t\u00E9 de droit des Pays-Bas Sterq Management B.V., ayant son si\u00E8ge \u00E0 Van den Eyndestraat 3, 2582 EA \u0027S-Gravenhage, Pays-Bas et enregistr\u00E9e aupr\u00E8s de la chambre de commerce n\u00E9erlandaise (Kamer van Koophandel) sous le num\u00E9ro KVK 75520583, ayant comme repr\u00E9s"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0845.590.372",
"name_full": "GOODLIFE PHARMA",
"legal_form": "SA"
}
}29-01-2024 2 directors appointed
- Megens, Lucy, Bestuurder
- Megens, Lucy, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Megens, Lucy",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0802784371",
"name": "LMW Management",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer comme administrateurs de la soci\u00E9t\u00E9 pour un mandat de six ans prenant fin imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e annuelle de 2030: - La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0022LMW Management\u0022, ayant son si\u00E8ge social \u00E0 2540 Hove, Mimosastraat 12, num\u00E9ro d\u0027entreprise 0802.784.371, RPM "
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Megens, Lucy",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0802784371",
"name": "LMW Management",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Le conseil d\u0027administration d\u00E9cide \u00E0 l\u0027unanimit\u00E9 des voix de nommer la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0022LMW Management\u0022 repr\u00E9sent\u00E9e de mani\u00E8re permanente par Megens Lucy comme administrateur d\u00E9l\u00E9gu\u00E9 pour un mandat de six ans prenant fin imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e annuelle de 2030."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0845.590.372",
"name_full": "GOODLIFE PHARMA",
"legal_form": "SA"
}
}16-11-2021 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0845.590.372",
"name_full": "GOODLIFE PHARMA",
"legal_form": "SA"
}
}20-12-2017 3 reappointed
- Frits Rooth, Bestuurder
- Nathalie Schewebach, Bestuurder
- Nathalie Schewebach, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Frits Rooth",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0845590372",
"name": "Goodlife Healthcare BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale du 30/06/2017 d\u00E9cide de renommer Goodlife Healthcare BV repr\u00E9sent\u00E9e par Frits Rooth et Schewebach SCS repr\u00E9sent\u00E9e par Nathalie Schewebach comme administrateurs Jusqu\u0027\u00E0 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale de 2023."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Nathalie Schewebach",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Schewebach SCS",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale du 30/06/2017 d\u00E9cide de renommer Goodlife Healthcare BV repr\u00E9sent\u00E9e par Frits Rooth et Schewebach SCS repr\u00E9sent\u00E9e par Nathalie Schewebach comme administrateurs Jusqu\u0027\u00E0 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale de 2023."
},
{
"kind": "director_renew",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Nathalie Schewebach",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Schewebach SCS",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Le Conseil d\u0027Administration du 30/06/2017 accepte et appelle le renouvellement du mandat de Schewebach SCS repr\u00E9sent\u00E9e par Nathalie Schewebach comme administrateur d\u00E9l\u00E9gu\u00E9 jusqu\u0027\u00E0 l\u0027administration g\u00E9n\u00E9rale de 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0845.590.372",
"name_full": "GOODLIFE PHARMA",
"legal_form": "SA"
}
}06-04-2016 Capital increase of €200,000 to €262,500
- €62.500 → €262.500
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 200000.0,
"currency": "EUR",
"after_eur": 262500.0,
"delta_eur": 200000.0,
"before_eur": 62500.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2016-03-17",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027une augmentation de capital de deux cents mille euros (\u20AC 200.000,00) pour porter le capital de soixante-deux mille cing cents euros (\u20AC 62.500,00) \u00E0 deux cent soixante-deux mille cing cents euros (\u20AC 262.500,00)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0845.590.372",
"name_full": "GOODLIFE PHARMA",
"legal_form": "SA"
}
}| Legal nameFR | GOODLIFE PHARMA |